Schedule 13G ownership disclosure

COEPTIS THERAPEUTICS HLDGS I

Security class unavailable · CUSIP: 19207A108

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
0
Percent of class
0.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001393825-23-000040
Form type
SC 13G/A
Filer
Coeptis Therapeutics Holdings, Inc.
CIK
CIK 1759186
Filed
Feb 06, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub